Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1993-3-24
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0007-1250
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
274-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8435711-Adult,
pubmed-meshheading:8435711-Catatonia,
pubmed-meshheading:8435711-Chlorpromazine,
pubmed-meshheading:8435711-Diagnosis, Differential,
pubmed-meshheading:8435711-Dose-Response Relationship, Drug,
pubmed-meshheading:8435711-Female,
pubmed-meshheading:8435711-Humans,
pubmed-meshheading:8435711-Neuroleptic Malignant Syndrome
|
pubmed:year |
1993
|
pubmed:articleTitle |
Catatonia and not neuroleptic malignant syndrome.
|
pubmed:publicationType |
Letter,
Comment
|